FindTrial
Sign In

Effectiveness and safety study of recurrent anterior shoulder dislocation treatment using autologous fascia lata

Effectiveness and safety study of recurrent anterior shoulder dislocation treatment using autologous fascia lata

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075480
Enrollment
Unknown
Registered
2023-09-06
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior unstable shoulder with subcritical bone defects

Interventions

Experimental group:labral reconstruction + labrocapsular suture
Control group:labrocapsular suture

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 2023.10-2024.10 Patients undergoing shoulder arthroscopic treatment due to forward shoulder instability of the shoulder joint, aged 18-50 years, the proportion of shoulder glenoid bone defects on the affected side is 5-15%

Exclusion criteria

Exclusion criteria: Combined with rotator cuff injury, tumor, joint adhesions, etc.; Osteoarthritis of the shoulder joint has been present; Deltoid muscle dysfunction due to axillary nerve injury.

Design outcomes

Primary

MeasureTime frame
anterior movement of humeral head;—

Secondary

MeasureTime frame
shoulder function;shoulder stability;shoulder range of motion;—

Countries

China

Contacts

Public ContactHong Chen

The First Affiliated Hospital of Chongqing Medical University

chhong113@126.com+86 135 9411 5158

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026